Literature DB >> 26299453

Interactions between Gut Microbiota, Host Genetics and Diet Modulate the Predisposition to Obesity and Metabolic Syndrome.

Siegfried Ussar1,2, Nicholas W Griffin3,4, Olivier Bezy1, Shiho Fujisaka1, Sara Vienberg1, Samir Softic1, Luxue Deng5, Lynn Bry5, Jeffrey I Gordon3,4, C Ronald Kahn1.   

Abstract

Obesity, diabetes, and metabolic syndrome result from complex interactions between genetic and environmental factors, including the gut microbiota. To dissect these interactions, we utilized three commonly used inbred strains of mice-obesity/diabetes-prone C57Bl/6J mice, obesity/diabetes-resistant 129S1/SvImJ from Jackson Laboratory, and obesity-prone but diabetes-resistant 129S6/SvEvTac from Taconic-plus three derivative lines generated by breeding these strains in a new, common environment. Analysis of metabolic parameters and gut microbiota in all strains and their environmentally normalized derivatives revealed strong interactions between microbiota, diet, breeding site, and metabolic phenotype. Strain-dependent and strain-independent correlations were found between specific microbiota and phenotypes, some of which could be transferred to germ-free recipient animals by fecal transplantation. Environmental reprogramming of microbiota resulted in 129S6/SvEvTac becoming obesity resistant. Thus, development of obesity/metabolic syndrome is the result of interactions between gut microbiota, host genetics, and diet. In permissive genetic backgrounds, environmental reprograming of microbiota can ameliorate development of metabolic syndrome.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26299453      PMCID: PMC4570502          DOI: 10.1016/j.cmet.2015.07.007

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  46 in total

1.  Differential colonization with segmented filamentous bacteria and Lactobacillus murinus do not drive divergent development of diet-induced obesity in C57BL/6 mice.

Authors:  Isaac T W Harley; Daniel A Giles; Paul T Pfluger; Stacey L Burgess; Stephanie Walters; Jazzminn Hembree; Christine Raver; Cheryl L Rewerts; Jordan Downey; Leah M Flick; Traci E Stankiewicz; Jaclyn W McAlees; Marsha Wills-Karp; R Balfour Sartor; Senad Divanovic; Matthias H Tschöp; Christopher L Karp
Journal:  Mol Metab       Date:  2013-05-10       Impact factor: 7.422

2.  A metagenome-wide association study of gut microbiota in type 2 diabetes.

Authors:  Junjie Qin; Yingrui Li; Zhiming Cai; Shenghui Li; Jianfeng Zhu; Fan Zhang; Suisha Liang; Wenwei Zhang; Yuanlin Guan; Dongqian Shen; Yangqing Peng; Dongya Zhang; Zhuye Jie; Wenxian Wu; Youwen Qin; Wenbin Xue; Junhua Li; Lingchuan Han; Donghui Lu; Peixian Wu; Yali Dai; Xiaojuan Sun; Zesong Li; Aifa Tang; Shilong Zhong; Xiaoping Li; Weineng Chen; Ran Xu; Mingbang Wang; Qiang Feng; Meihua Gong; Jing Yu; Yanyan Zhang; Ming Zhang; Torben Hansen; Gaston Sanchez; Jeroen Raes; Gwen Falony; Shujiro Okuda; Mathieu Almeida; Emmanuelle LeChatelier; Pierre Renault; Nicolas Pons; Jean-Michel Batto; Zhaoxi Zhang; Hua Chen; Ruifu Yang; Weimou Zheng; Songgang Li; Huanming Yang; Jian Wang; S Dusko Ehrlich; Rasmus Nielsen; Oluf Pedersen; Karsten Kristiansen; Jun Wang
Journal:  Nature       Date:  2012-09-26       Impact factor: 49.962

Review 3.  Gut bacterial microbiota and obesity.

Authors:  M Million; J-C Lagier; D Yahav; M Paul
Journal:  Clin Microbiol Infect       Date:  2013-03-02       Impact factor: 8.067

4.  Intestinal epithelial cell toll-like receptor 5 regulates the intestinal microbiota to prevent low-grade inflammation and metabolic syndrome in mice.

Authors:  Benoit Chassaing; Ruth E Ley; Andrew T Gewirtz
Journal:  Gastroenterology       Date:  2014-08-27       Impact factor: 22.682

5.  Identification of interactive loci linked to insulin and leptin in mice with genetic insulin resistance.

Authors:  Katrine Almind; Rohit N Kulkarni; Scott M Lannon; C Ronald Kahn
Journal:  Diabetes       Date:  2003-06       Impact factor: 9.461

6.  Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels.

Authors:  Richa Saxena; Benjamin F Voight; Valeriya Lyssenko; Noël P Burtt; Paul I W de Bakker; Hong Chen; Jeffrey J Roix; Sekar Kathiresan; Joel N Hirschhorn; Mark J Daly; Thomas E Hughes; Leif Groop; David Altshuler; Peter Almgren; Jose C Florez; Joanne Meyer; Kristin Ardlie; Kristina Bengtsson Boström; Bo Isomaa; Guillaume Lettre; Ulf Lindblad; Helen N Lyon; Olle Melander; Christopher Newton-Cheh; Peter Nilsson; Marju Orho-Melander; Lennart Råstam; Elizabeth K Speliotes; Marja-Riitta Taskinen; Tiinamaija Tuomi; Candace Guiducci; Anna Berglund; Joyce Carlson; Lauren Gianniny; Rachel Hackett; Liselotte Hall; Johan Holmkvist; Esa Laurila; Marketa Sjögren; Maria Sterner; Aarti Surti; Margareta Svensson; Malin Svensson; Ryan Tewhey; Brendan Blumenstiel; Melissa Parkin; Matthew Defelice; Rachel Barry; Wendy Brodeur; Jody Camarata; Nancy Chia; Mary Fava; John Gibbons; Bob Handsaker; Claire Healy; Kieu Nguyen; Casey Gates; Carrie Sougnez; Diane Gage; Marcia Nizzari; Stacey B Gabriel; Gung-Wei Chirn; Qicheng Ma; Hemang Parikh; Delwood Richardson; Darrell Ricke; Shaun Purcell
Journal:  Science       Date:  2007-04-26       Impact factor: 47.728

7.  Lymphotoxin regulates commensal responses to enable diet-induced obesity.

Authors:  Vaibhav Upadhyay; Valeriy Poroyko; Tae-jin Kim; Suzanne Devkota; Sherry Fu; Donald Liu; Alexei V Tumanov; Ekaterina P Koroleva; Liufu Deng; Cathryn Nagler; Eugene B Chang; Hong Tang; Yang-Xin Fu
Journal:  Nat Immunol       Date:  2012-08-26       Impact factor: 25.606

8.  Richness of human gut microbiome correlates with metabolic markers.

Authors:  Emmanuelle Le Chatelier; Trine Nielsen; Junjie Qin; Edi Prifti; Falk Hildebrand; Gwen Falony; Mathieu Almeida; Manimozhiyan Arumugam; Jean-Michel Batto; Sean Kennedy; Pierre Leonard; Junhua Li; Kristoffer Burgdorf; Niels Grarup; Torben Jørgensen; Ivan Brandslund; Henrik Bjørn Nielsen; Agnieszka S Juncker; Marcelo Bertalan; Florence Levenez; Nicolas Pons; Simon Rasmussen; Shinichi Sunagawa; Julien Tap; Sebastian Tims; Erwin G Zoetendal; Søren Brunak; Karine Clément; Joël Doré; Michiel Kleerebezem; Karsten Kristiansen; Pierre Renault; Thomas Sicheritz-Ponten; Willem M de Vos; Jean-Daniel Zucker; Jeroen Raes; Torben Hansen; Peer Bork; Jun Wang; S Dusko Ehrlich; Oluf Pedersen
Journal:  Nature       Date:  2013-08-29       Impact factor: 49.962

9.  Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity.

Authors:  Jorge Henao-Mejia; Eran Elinav; Chengcheng Jin; Liming Hao; Wajahat Z Mehal; Till Strowig; Christoph A Thaiss; Andrew L Kau; Stephanie C Eisenbarth; Michael J Jurczak; Joao-Paulo Camporez; Gerald I Shulman; Jeffrey I Gordon; Hal M Hoffman; Richard A Flavell
Journal:  Nature       Date:  2012-02-01       Impact factor: 49.962

10.  Obesity-associated gut microbiota is enriched in Lactobacillus reuteri and depleted in Bifidobacterium animalis and Methanobrevibacter smithii.

Authors:  M Million; M Maraninchi; M Henry; F Armougom; H Richet; P Carrieri; R Valero; D Raccah; B Vialettes; D Raoult
Journal:  Int J Obes (Lond)       Date:  2011-08-09       Impact factor: 5.095

View more
  191 in total

1.  Obesity: Gut microbiota, host genetics and diet interact to affect the risk of developing obesity and the metabolic syndrome.

Authors:  Claire Greenhill
Journal:  Nat Rev Endocrinol       Date:  2015-09-08       Impact factor: 43.330

Review 2.  'Inside Out'- a dialogue between mitochondria and bacteria.

Authors:  Bing Han; Chih-Chun Janet Lin; Guo Hu; Meng C Wang
Journal:  FEBS J       Date:  2018-11-21       Impact factor: 5.542

Review 3.  The human symbiont Mucispirillum schaedleri: causality in health and disease.

Authors:  Simone Herp; Abilash Chakravarthy Durai Raj; Marta Salvado Silva; Simon Woelfel; Bärbel Stecher
Journal:  Med Microbiol Immunol       Date:  2021-05-22       Impact factor: 3.402

4.  Specific features of colorectal cancer in patients with metabolic syndrome: a matched case-control analysis of 772 patients.

Authors:  Alban Zarzavadjian Le Bian; Christine Denet; Nicolas Tabchouri; Gianfranco Donatelli; Philippe Wind; Christophe Louvet; Mostefa Bennamoun; Christos Christidis; Thierry Perniceni; David Fuks; Brice Gayet
Journal:  Langenbecks Arch Surg       Date:  2018-04-27       Impact factor: 3.445

5.  Host Genotype and Gut Microbiome Modulate Insulin Secretion and Diet-Induced Metabolic Phenotypes.

Authors:  Julia H Kreznar; Mark P Keller; Lindsay L Traeger; Mary E Rabaglia; Kathryn L Schueler; Donald S Stapleton; Wen Zhao; Eugenio I Vivas; Brian S Yandell; Aimee Teo Broman; Bruno Hagenbuch; Alan D Attie; Federico E Rey
Journal:  Cell Rep       Date:  2017-02-14       Impact factor: 9.423

6.  Inhibition of the IL-17A axis in adipocytes suppresses diet-induced obesity and metabolic disorders in mice.

Authors:  Ana Teijeiro; Amanda Garrido; Anna Ferre; Cristian Perna; Nabil Djouder
Journal:  Nat Metab       Date:  2021-04-15

Review 7.  Determinants of nutrient limitation in cancer.

Authors:  Mark R Sullivan; Matthew G Vander Heiden
Journal:  Crit Rev Biochem Mol Biol       Date:  2019-06-04       Impact factor: 8.250

Review 8.  Gut microbiota: a new path to treat obesity.

Authors:  Giovanna Muscogiuri; Elena Cantone; Sara Cassarano; Dario Tuccinardi; Luigi Barrea; Silvia Savastano; Annamaria Colao
Journal:  Int J Obes Suppl       Date:  2019-04-12

Review 9.  Global aetiology and epidemiology of type 2 diabetes mellitus and its complications.

Authors:  Yan Zheng; Sylvia H Ley; Frank B Hu
Journal:  Nat Rev Endocrinol       Date:  2017-12-08       Impact factor: 43.330

10.  Antibiotics-mediated intestinal microbiome perturbation aggravates tacrolimus-induced glucose disorders in mice.

Authors:  Yuqiu Han; Xiangyang Jiang; Qi Ling; Li Wu; Pin Wu; Ruiqi Tang; Xiaowei Xu; Meifang Yang; Lijiang Zhang; Weiwei Zhu; Baohong Wang; Lanjuan Li
Journal:  Front Med       Date:  2019-05-02       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.